Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-15 Purchase | 2022-02-17 4:00 pm | Kintara Therapeutics Inc. | KTRA | Hoffman Robert E. President and CEO | 55,000 | $0.469 | $25,795 | 55,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-27 Option Award | 2024-08-27 7:53 pm | N/A 2034-08-26 | FibroBiologics Inc. | FBLG | Hoffman Robert E. Director | 5,000 | $0 | 5,000 (Direct) | View |
Ownership(A) | 2024-08-13 4:01 pm | N/A 2033-02-16 | FibroBiologics Inc. | FBLG | Hoffman Robert E. Director | 0 | $0 | 190,300 (Direct) | View |
Ownership | 2024-02-07 7:45 pm | N/A N/A | FibroBiologics Inc. | FBLG | Hoffman Robert E. Director | 0 | $0 | 7,500 (Direct) | View |
| 2023-08-30 Option Award | 2023-09-01 6:00 pm | N/A 2033-08-30 | Kintara Therapeutics Inc. | KTRA | Hoffman Robert E. President, CEO and Interim CFO | 23,142 | $0 | 23,142 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:05 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Hoffman Robert E. President, CEO, and CFO | 59,800 | $0 | 68,902 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-03 4:30 pm | N/A 2022-08-02 | Kintara Therapeutics Inc. | KTRA | Hoffman Robert E. President and CEO | 1,600,779 | $0 | 1,655,779 (Direct) | View |
| 2021-11-08 Option Award | 2021-11-10 4:18 pm | N/A 2031-11-08 | Kintara Therapeutics Inc. | KTRA | HOFFMAN ROBERT President and CEO | 3,519,170 | $0 | 3,519,170 (Direct) | View |
| 2021-09-22 Option Award | 2021-09-22 8:35 pm | N/A 2031-09-22 | Kintara Therapeutics Inc. | KTRA | HOFFMAN ROBERT Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-23 5:14 pm | N/A 2031-06-21 | Kura Oncology Inc. | KURA | HOFFMAN ROBERT Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2020-09-15 Option Award | 2020-09-17 9:05 pm | N/A 2030-09-15 | Kintara Therapeutics Inc. | KTRA | HOFFMAN ROBERT Director | 120,000 | $0 | 120,000 (Direct) | View |
| 2020-06-26 Option Award | 2020-06-30 4:11 pm | N/A 2029-09-05 | DelMar Pharmaceuticals Inc. | DMPI | HOFFMAN ROBERT Director | 39,567 | $0 | 75,000 (Direct) | View |
| 2020-06-24 Option Award | 2020-06-26 4:06 pm | N/A 2030-06-23 | Kura Oncology Inc. | KURA | HOFFMAN ROBERT Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2019-12-19 Option Award | 2019-12-23 4:28 pm | N/A 2029-12-19 | HERON THERAPEUTICS INC. | HRTX | HOFFMAN ROBERT CFO & SVP, Finance | 100,000 | $0 | 100,000 (Direct) | View |